Registered Kenya · PPB

DAZOLON-100

DAZOLON USP

What it does

Dazolon is a medication that may be used for various health conditions.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
20484
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
DAZOLON USP
Dosage form
DAZOLON USP 100MG
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Surgilinks
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
MRGV+VXV, Mombasa Road, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:13:23 · updated 2026-07-20 08:56:33

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Dazolon is a medication that may be used for various health conditions.

How it works

Dazolon works by affecting certain processes in the body to help treat specific conditions.

Who it's for

Dazolon is typically prescribed for adults and may be used in children under medical supervision.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: dazolon

Dazolon is a pharmaceutical agent primarily used as an anti-inflammatory and analgesic medication. It belongs to a class of drugs known for their ability to reduce inflammation and provide pain relief. It is often utilized in the treatment of various conditions, including rheumatic disorders and other inflammatory diseases.

Indications

  • Rheumatoid arthritis
  • Osteoarthritis
  • Ankylosing spondylitis
  • Gouty arthritis
  • Acute musculoskeletal pain
  • Postoperative pain

Dosage

Children: Refer to the specific prescribing information for dosing recommendations.

Adults: Refer to the specific prescribing information for dosing recommendations.

Mechanism of action

Dazolon exerts its effects by inhibiting the synthesis of prostaglandins, which are lipid compounds that play a key role in mediating inflammation and pain. By blocking the enzyme cyclooxygenase (COX), which is responsible for converting arachidonic acid to prostaglandins, dazolon effectively reduces the inflammatory response and alleviates pain.

Pharmacodynamics

Dazolon demonstrates anti-inflammatory, analgesic, and antipyretic properties. Its action leads to a decrease in the sensitivity of pain receptors and diminishes the overall inflammatory process in affected tissues. This results in reduced swelling, redness, and pain, contributing to improved patient comfort and functionality.

Pharmacokinetics

Dazolon is absorbed from the gastrointestinal tract, with peak plasma concentrations typically occurring within a few hours after administration. It has a moderate volume of distribution and is extensively metabolized in the liver, with metabolites excreted primarily in urine. The drug has a half-life that varies depending on individual patient factors, influencing dosing frequency and duration of therapy.

Pregnancy

The safety of dazolon during pregnancy has not been established. It should be used only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

It is not known whether dazolon is excreted in human milk. Caution should be exercised when administering to nursing mothers.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.